Alliance between Philips, Maastricht UMC+ and University Clinic Aachen

Royal Philips ElectronicsThe Maastricht University Medical Centre (UMC+), University Medical Center Aachen (UKA) and Royal Philips Electronics N.V. announced that they are to set up a strategic partnership, the aim of which is to pool their knowledge, expertise and experience in the field of healthcare. The planned cooperation will make it possible for new scientific findings to be made available more quickly for routine application in hospitals, thus benefiting patients. The universities of Aachen and Maastricht are also supporting the initiative.

Among others, Prof. Henning Saß and Guy Peeters MD, chairmen of the Boards of Management of the Aachen and Maastricht medical centers respectively, Dr. Henk van Houten, head of the Healthcare Research Program at Philips Research, and Jochen Franke, CEO Philips Healthcare DACH (Germany, Austria and Switzerland), signed a letter of intent at the 'Biomedica 2008' international Life Science Summit in Maastricht, the Netherlands. The signing took place in the presence of Mrs M. van der Hoeven and Mrs C. Thoben, Ministers of Economic Affairs for the Netherlands and the German federal state of North-Rhine Westphalia respectively, and Prof. Andreas Pinkwart, Minister for Research and Innovation in North-Rhine Westphalia.

Philips and the two university medical centers intend to work closely together and to combine their advanced clinical knowledge and research specifically in the fields of cardiovascular disease and cancer treatment. Their cooperation will cover the research, development and application of new diagnostic and treatment methods. Among other things, the partners' aim is to set up a joint research program in the field of medical imaging technology.

"Shortages in the labor market and increasing competition in the healthcare sector are making it increasingly important to set up international joint ventures to ensure that we can continue bringing about the necessary innovation. National boundaries should not be a barrier to this," says G. Peeters MD, chairman of the Board of Management of the Maastricht UMC+.

Prof. Henning Saß, chairman of the Board of Management of the University Clinic in Aachen comments, "This will benefit both the patient and the participating partners, because it will enable us all to strengthen our European and international competitive position."

Dr. Henk van Houten, Senior Vice President Philips Research, who is in charge of the healthcare research program at Philips Research, adds, "This alliance will give rise to advanced clinical care, as well as ground-breaking clinical research to find an integrated approach to diagnosis and therapy for cancer and cardiovascular disease. The opportunity to work together with highly reputable academic partners in order to link clinical research and healthcare to the application of new medical technologies represents a very exciting prospect for Philips."

Related news articles:

About Royal Philips Electronics
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a global leader in healthcare, lighting and consumer lifestyle, delivering people-centric, innovative products, services and solutions through the brand promise of "sense and simplicity". Headquartered in the Netherlands, Philips employs approximately 134,200 employees in more than 60 countries worldwide. With sales of EUR 27 billion in 2007, the company is a market leader in medical diagnostic imaging and patient monitoring systems, energy efficient lighting solutions, as well as lifestyle solutions for personal wellbeing. News from Philips is located at www.philips.com/newscenter.

Most Popular Now

AI Body Composition Measurements can Pre…

Adiposity - or the accumulation of excess fat in the body - is a known driver of cardiometabolic diseases such as heart disease, stroke, type 2 diabetes, and kidney disease...

AI can Strengthen Pandemic Preparedness

How to identify the next dangerous virus before it spreads among people is the central question in a new Comment in The Lancet Infectious Diseases. In it, researchers discuss how...

'Future-Guided' AI Improves Se…

In the world around us, many things exist in the context of time: a bird’s path through the sky is understood as different positions over a period of time, and...

New AI Tool Scans Social Media for Hidde…

A new artificial intelligence tool can scan social media data to discover adverse events associated with consumer health products, according to a study published September 30th in the open-access journal...

Study Finds One-Year Change on CT Scans …

Researchers at National Jewish Health have shown that subtle increases in lung scarring, detected by an artificial intelligence-based tool on CT scans taken one year apart, are associated with disease...

Yousif's Story with Sectra and The …

Embarking on healthcare technology career after leaving his home as a refugee during his teenage years, Yousif is passionate about making a difference. He reflects on an apprenticeship in which...

New AI Tools Help Scientists Track How D…

Artificial intelligence (AI) can solve problems at remarkable speed, but it’s the people developing the algorithms who are truly driving discovery. At The University of Texas at Arlington, data scientists...

AI Tool Offers Deep Insight into the Imm…

Researchers explore the human immune system by looking at the active components, namely the various genes and cells involved. But there is a broad range of these, and observations necessarily...

New Antibiotic Targets IBD - and AI Pred…

Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs at once: they not only discovered a brand-new antibiotic that targets inflammatory bowel diseases...

Highland to Help Companies Seize 'N…

Health tech growth partner Highland has today revealed its new identity - reflecting a sharper focus as it helps health tech companies to find market opportunities, convince target audiences, and...